BioNTech SE Income Statement

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.07B0.15B0.12B0.58B21.71B18.24B4.11B2.94B
Cost of Revenue 0.01B0.02B0.02B0.07B3.33B3.16B0.65B0.58B
Gross Profit 0.06B0.13B0.10B0.50B18.38B15.09B3.46B2.36B
Operating items
Research & Development 0.10B0.17B0.25B0.77B1.09B1.62B1.92B2.41B
Share-based Compensation (IS) -0.02B-0.05B-0.82B-0.17B
Selling, General & Administrative 0.03B0.03B0.05B0.11B0.32B0.51B0.53B0.57B
Other Operating Expenses 0.00B0.01B0.00B
Operating Expenses 0.12B0.20B0.30B0.88B1.40B2.13B2.45B2.98B
Operating Income -0.07B-0.06B-0.20B-0.10B17.48B13.32B0.74B-1.40B
EBIT -0.07B-0.06B-0.20B-0.10B17.48B13.32B0.74B-1.40B
Non-operating items
Interest & Investment Income 0.00B0.01B0.00B0.00B0.08B0.35B0.56B0.71B
Non Operating Income 0.00B-0.00B
Net income details
EBT -0.10B-0.06B-0.20B-0.17B17.21B13.65B1.28B-0.72B
Tax Provisions 0.00B0.00B-0.00B-0.19B5.44B3.71B0.28B-0.01B
Profit After Tax -0.10B-0.06B-0.20B0.02B11.77B9.94B1.00B-0.71B
Equity Income -0.00B-0.00B
Income from Non-Controlling Interests -0.00B-0.00B-0.00B
Income from Continuing Operations -0.10B-0.06B-0.20B0.02B11.77B9.94B1.00B-0.71B
Consolidated Net Income -0.10B-0.06B-0.20B0.02B11.77B9.94B1.00B-0.71B
Income towards Parent Company -0.10B-0.06B-0.20B0.02B11.77B9.94B1.00B-0.71B
Net Income towards Common Stockholders -0.10B-0.06B-0.20B0.02B11.77B9.94B1.00B-0.71B
Additional items
EPS (Basic) -0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B-0.00B
EPS (Weighted Average and Diluted) -0.00B0.00B0.00B0.00B0.00B-0.00B
Shares Outstanding (Weighted Average) 0.23B0.23B0.23B0.24B0.24B0.24B0.24B
EBITDA -0.07B-0.06B-0.20B-0.10B17.48B13.32B0.74B-1.40B
Tax Rate 0.11%31.59%27.17%21.57%1.83%